22,23-dihydrobrassicasterol

22,23-dihydrobrassicasterol is a lipid of Sterol Lipids (ST) class. 22,23-dihydrobrassicasterol is associated with abnormalities such as Diabetes, Macular degeneration, Drusen, Systemic disease and Diabetes Mellitus. The involved functions are known as cholesterol metabolism, Synthesis, Intestinal Absorption, Liver function and cholesterol absorption. 22,23-dihydrobrassicasterol often locates in Back and Cell membrane. The associated genes with 22,23-dihydrobrassicasterol are apolipoprotein E-3. The related lipids are Total cholesterol, campesterol, lathosterol, Fatty Acids, Nonesterified and Cholesterol, Dietary.

Cross Reference

Introduction

To understand associated biological information of 22,23-dihydrobrassicasterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 22,23-dihydrobrassicasterol?

22,23-dihydrobrassicasterol is suspected in Diabetes, Macular degeneration, Drusen, Systemic disease, Diabetes Mellitus, Liver diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 22,23-dihydrobrassicasterol

MeSH term MeSH ID Detail
Coronary Disease D003327 70 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Hyperlipidemias D006949 73 associated lipids
Hypolipoproteinemias D007009 9 associated lipids
Xanthomatosis D014973 17 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Total 7

PubChem Associated disorders and diseases

What pathways are associated with 22,23-dihydrobrassicasterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 22,23-dihydrobrassicasterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 22,23-dihydrobrassicasterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 22,23-dihydrobrassicasterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 22,23-dihydrobrassicasterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 22,23-dihydrobrassicasterol?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 22,23-dihydrobrassicasterol

Download all related citations
Per page 10 20 50 100 | Total 313
Authors Title Published Journal PubMed Link
Howell TJ et al. Phytosterols partially explain differences in cholesterol metabolism caused by corn or olive oil feeding. 1998 J. Lipid Res. pmid:9555952
Field FJ et al. Effect of micellar beta-sitosterol on cholesterol metabolism in CaCo-2 cells. 1997 J. Lipid Res. pmid:9162754
Robins SJ and Fasulo JM High density lipoproteins, but not other lipoproteins, provide a vehicle for sterol transport to bile. 1997 J. Clin. Invest. pmid:9022069
Fujioka S et al. The Arabidopsis deetiolated2 mutant is blocked early in brassinosteroid biosynthesis. 1997 Plant Cell pmid:9401120
Gylling H and Miettinen TA Cholesterol absorption, synthesis, and LDL metabolism in NIDDM. 1997 Diabetes Care pmid:9028702
Sakurai A and Fujioka S Studies on biosynthesis of brassinosteroids. 1997 Biosci. Biotechnol. Biochem. pmid:9178548
Ling WH and Jones PJ Enhanced efficacy of sitostanol-containing versus sitostanol-free phytosterol mixtures in altering lipoprotein cholesterol levels and synthesis in rats. 1995 Atherosclerosis pmid:8770325
Locker PK et al. Lifibrol: a novel lipid-lowering drug for the therapy of hypercholesterolemia. Lifibrol Study Group. 1995 Clin. Pharmacol. Ther. pmid:7828385
Lütjohann D et al. Sterol absorption and sterol balance in phytosterolemia evaluated by deuterium-labeled sterols: effect of sitostanol treatment. 1995 J. Lipid Res. pmid:7595097
Miettinen TA et al. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. 1995 N. Engl. J. Med. pmid:7566021
Davis RH et al. Aloe vera, hydrocortisone, and sterol influence on wound tensile strength and anti-inflammation. 1994 J Am Podiatr Med Assoc pmid:7853156
Zeeck E et al. Sex pheromones in marine polychaetes: steroids from ripe Nereis succinea. 1994 Steroids pmid:8073448
Heinemann T et al. Comparison of intestinal absorption of cholesterol with different plant sterols in man. 1993 Eur. J. Clin. Invest. pmid:8143759
Sutherland WH et al. Plasma non-cholesterol sterols in patients with non-insulin dependent diabetes mellitus. 1992 Horm. Metab. Res. pmid:1601392
Vanhanen HT and Miettinen TA Effects of unsaturated and saturated dietary plant sterols on their serum contents. 1992 Clin. Chim. Acta pmid:1521345
Nikkilä K et al. Liver transplantation modifies serum cholestanol, cholesterol precursor and plant sterol levels. 1992 Clin. Chim. Acta pmid:1499139
van Dusseldorp M et al. Cholesterol-raising factor from boiled coffee does not pass a paper filter. 1991 May-Jun Arterioscler. Thromb. pmid:2029499
Kempen HJ et al. Lathosterol level in plasma is elevated in type III hyperlipoproteinemia, but not in non-type III subjects with apolipoprotein E2/2 phenotype, nor in type IIa or IIb hyperlipoproteinemia. 1991 Metab. Clin. Exp. pmid:2000034
Bhadra S and Subbiah MT Incorporation of liposomal phytosterols into human cells in culture: a potential in vitro model for investigating pathological effects of phytosterolemia. 1991 Biochem. Med. Metab. Biol. pmid:1931153
Nikkilä K et al. High cholestanol and low campesterol-to-sitosterol ratio in serum of patients with primary biliary cirrhosis before liver transplantation. 1991 Hepatology pmid:2010161